Inflation is out of Open Letter territory for the second month in a row, which is good news and is providing some welcome relief for family budgets.
More top news
Niraparib is a PARP inhibitor belonging to a new class of drugs that target cancers with defective DNA repair systems.
According to the EU, during the transition period the UK would have to comply with the bloc's trade policy.
Turning mild for the middle of the week.